Artesunate (Injection)
The WHO gold standard for severe malaria. It works much faster than quinine and has a better safety profile. Must be followed by a full course of oral ACT.
Dosage by Body Weight
Pediatric dose: 3 mg/kg (for children <20kg) or 2.4 mg/kg (for >20kg) at 0, 12, and 24 hours, then daily.
- Body Weight
- 5-10 kg
- Dose
- 15 mg to 30 mg
- Frequency
- At 0, 12, and 24 hours (IV/IM)
- Tracking Notes
- Life-saving emergency treatment.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| 5-10 kg | 15 mg to 30 mg | At 0, 12, and 24 hours (IV/IM) | Life-saving emergency treatment. |
Formulation
Purpose
Emergency treatment of severe malaria in children and adults.
Generic Name
ArtesunateBranded Drug Names
Artesunate (Injection) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONArtesunate (Injection): Alcohol may increase dizziness, stomach upset, dehydration, or other side effects. Avoid or limit alcohol and follow medical advice.
Pregnancy
SAFE IF PRESCRIBEDArtesunate (Injection): Use during pregnancy only if prescribed after a healthcare provider weighs the benefits and risks.
Breast Feeding
SAFE IF PRESCRIBEDArtesunate (Injection): Use while breastfeeding only with healthcare provider guidance, especially for repeated or long-term treatment.
Driving
CAUTIONArtesunate (Injection): This medicine may cause dizziness, drowsiness, weakness, or blurred vision in some people. Avoid driving if affected.
Liver
CAUTIONArtesunate (Injection): Use with caution in liver disease and consult your healthcare provider if you have abnormal liver tests or jaundice.
Kidney
CAUTIONArtesunate (Injection): Use with caution in kidney disease because dose adjustment or monitoring may be needed for some patients.